within Pharmacolibrary.Drugs.ATC.C;

model C03AA03
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.65,
    Cl             = 0.0018166666666666667,
    adminDuration  = 600,
    adminMass      = 25 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.0036,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.012166666666666666,
    Tlag           = 9.0
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>C03AA03</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Hydrochlorothiazide is a thiazide diuretic commonly used to treat hypertension, edema associated with congestive heart failure, liver cirrhosis, and chronic kidney disease. It reduces blood pressure by promoting the excretion of sodium and water in the kidneys. Hydrochlorothiazide is widely approved and used in clinical practice.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters in healthy adults following oral administration.</p><h4>References</h4><ol><li><p>Sica, DA, et al., &amp; Ghosh, S (2005). Clinical pharmacokinetics of losartan. <i>Clinical pharmacokinetics</i> 44(8) 797–814. DOI:<a href=&quot;https://doi.org/10.2165/00003088-200544080-00003&quot;>10.2165/00003088-200544080-00003</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/16029066/&quot;>https://pubmed.ncbi.nlm.nih.gov/16029066</a></p></li><li><p>Ngo, L, et al., &amp; Lee, YB (2018). Effects of hydrochlorothiazide and amlodipine on single oral dose pharmacokinetics of valsartan in healthy Korean subjects: Population model-based approach. <i>European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences</i> 118 154–164. DOI:<a href=&quot;https://doi.org/10.1016/j.ejps.2018.03.031&quot;>10.1016/j.ejps.2018.03.031</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/29604332/&quot;>https://pubmed.ncbi.nlm.nih.gov/29604332</a></p></li><li><p>Barbhaiya, RH, et al., &amp; Welling, PG (1982). Comparative bioavailability and pharmacokinetics of hydrochlorothiazide from oral tablet dosage forms, determined by plasma level and urinary excretion methods. <i>Biopharmaceutics &amp; drug disposition</i> 3(4) 329–336. DOI:<a href=&quot;https://doi.org/10.1002/bdd.2510030406&quot;>10.1002/bdd.2510030406</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/7159688/&quot;>https://pubmed.ncbi.nlm.nih.gov/7159688</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end C03AA03;
